Home > News > Industry > Pharma News > Serum Institute to try to...

Serum Institute to try to supply more doses of COVID-19 vaccine to UK later

By - Ruchika Sharma
Published On 2021-03-20 07:06 GMT   |   Update On 2021-03-20 07:06 GMT

New Delhi: Serum Institute of India (SII) has said it will try to supply more doses of Oxford-AstraZeneca Covid-19 vaccine to the United Kingdom later, based on the current situation and requirement for the government immunisation programme in India. The UK's National Health Service has warned of a significant reduction in weekly supplies of vaccines to protect against Covid-19 by the end of...

Login or Register to read the full article
Register Now

New Delhi: Serum Institute of India (SII) has said it will try to supply more doses of Oxford-AstraZeneca Covid-19 vaccine to the United Kingdom later, based on the current situation and requirement for the government immunisation programme in India.

The UK's National Health Service has warned of a significant reduction in weekly supplies of vaccines to protect against Covid-19 by the end of this month.

When contacted, a spokesperson for SII said, "Five million doses had been delivered a few weeks ago to the UK and we will try to supply more later, based on the current situation and requirement for the government immunisation programme in India".
Last month, SII CEO Adar Poonawalla had urged other countries to be patient as they wait for the supplies of Covid-19 vaccine, Covishield, as the company has been directed to prioritise the needs of India.
Apart from making efforts to meet the requirements of India, the vaccine major is also trying its best to balance the needs of the rest of the world, he had said.
"Dear countries and governments,     as you await #COVISHIELD supplies, I humbly request you to please be patient, @SerumInstIndia has been directed to prioritise the huge needs of India and along with that balance the needs of the rest of the world. We are trying our best", Poonawalla had said in a tweet.

Read also: SII gets purchase order from Govt for 10 crore Covishield doses



Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

"Safety is primary focus for all our vaccines": Covaxin-developer Bharat Biotech
Caplin Point gets Colombia nod for Softgel Capsules division
AstraZeneca concludes equity investment agreement with Cellectis
Alembic Pharma gets USFDA EIR for Panelav Oncology formulation facility
Cipla, Glenmark recall products from American market over manufacturing issues
Bharat Biotech International Gets CDSCO Panel Nod to Study Mycobacterium Tuberculosis Live Attenuated Vaccine
JnJ submits regulatory applications to EMA for Tremfya for treatment of patients with ulcerative colitis, Crohn's disease
Sentynl Therapeutics, a Zydus company acquires Zokinvy for Progeria from Eiger Biopharma